125 related articles for article (PubMed ID: 8055640)
1. Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities.
Ruggeri BA; Bauer B; Zhang SY; Klein-Szanto AJ
Carcinogenesis; 1994 Aug; 15(8):1613-9. PubMed ID: 8055640
[TBL] [Abstract][Full Text] [Related]
2. Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene.
Mitsunaga SI; Zhang SY; Ruggeri BA; Gimenez-Conti I; Robles AI; Conti CJ; Klein-Szanto AJ
Carcinogenesis; 1995 Jul; 16(7):1629-35. PubMed ID: 7542177
[TBL] [Abstract][Full Text] [Related]
3. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.
Ruggeri B; DiRado M; Zhang SY; Bauer B; Goodrow T; Klein-Szanto AJ
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1013-7. PubMed ID: 8430068
[TBL] [Abstract][Full Text] [Related]
4. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
6. Correlation between p53 mutation and cyclin D1 amplification in had and neck squamous cell carcinoma.
Mineta H; Borg A; Dictor M; Wahlberg P; Wennerberg J
Oral Oncol; 1997 Jan; 33(1):42-6. PubMed ID: 9192552
[TBL] [Abstract][Full Text] [Related]
7. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines.
Xu L; Davidson BJ; Murty VV; Li RG; Sacks PG; Garin-Chesa P; Schantz SP; Chaganti RS
Int J Cancer; 1994 Nov; 59(3):383-7. PubMed ID: 7927946
[TBL] [Abstract][Full Text] [Related]
8. Lack of concordant p53 mutations in some paired primary and metastatic mouse squamous cell carcinomas induced by chemical carcinogenesis.
Zhang SY; Bauer B; Mitsunaga S; Goodrow TL; Klein-Szanto AJ
Mol Carcinog; 1995 Feb; 12(2):77-81. PubMed ID: 7662119
[TBL] [Abstract][Full Text] [Related]
9. Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice.
Martin KR; Trempus C; Saulnier M; Kari FW; Barrett JC; French JE
Carcinogenesis; 2001 Sep; 22(9):1373-8. PubMed ID: 11532857
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
11. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.
Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE
Cell Biol Toxicol; 1997 Oct; 13(6):419-34. PubMed ID: 9352120
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
13. Analysis of p53 tumor suppressor gene, H-ras protooncogene and proliferating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy).
Lambertini L; Surin K; Ton TV; Clayton N; Dunnick JK; Kim Y; Hong HH; Devereux TR; Sills RC
Toxicol Pathol; 2005; 33(2):292-9. PubMed ID: 15902973
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines.
Kurzrock R; Ku S; Talpaz M
Cancer; 1995 Jan; 75(2):584-90. PubMed ID: 7812927
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
Uchimaru K; Endo K; Fujinuma H; Zukerberg L; Arnold A; Motokura T
Jpn J Cancer Res; 1996 May; 87(5):459-65. PubMed ID: 8641982
[TBL] [Abstract][Full Text] [Related]
16. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.
Ruggeri B; Caamano J; Goodrow T; DiRado M; Bianchi A; Trono D; Conti CJ; Klein-Szanto AJ
Cancer Res; 1991 Dec; 51(24):6615-21. PubMed ID: 1742735
[TBL] [Abstract][Full Text] [Related]
18. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model.
Park NH; Gujuluva CN; Baek JH; Cherrick HM; Shin KH; Min BM
Oncogene; 1995 Jun; 10(11):2145-53. PubMed ID: 7784058
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG
Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388
[TBL] [Abstract][Full Text] [Related]
20. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
